{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:16:24Z","timestamp":1777979784748,"version":"3.51.4"},"reference-count":36,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s602835","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:00:18Z","timestamp":1777978818000},"page":"1-12","source":"Crossref","is-referenced-by-count":0,"title":["Optimal Piperacillin\/Tazobactam Dosing in Adults with Low Body Weight: A Population Pharmacokinetic and Simulation-Based Study"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Yu-Ju","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6807-6908","authenticated-orcid":true,"given":"Liang","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsun","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-2176","authenticated-orcid":true,"given":"Chien-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1586\/14787210.5.3.365","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jac\/48.2.259","volume":"48","author":"Kim","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"Roberts","year":"2014","journal-title":"Clinl Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jcph.505","volume":"55","author":"Chung","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"ofad305","DOI":"10.1093\/ofid\/ofad305","volume":"10","author":"Tilanus","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2023.1137975","volume":"Volume","author":"Shi","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1016\/S1473-3099(25)00155-0","volume":"25","author":"M\u00e4rtson","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2165\/11598930-000000000-00000","volume":"51","author":"McLeay","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/antibiotics10111390","volume":"10","author":"Jang","year":"2021","journal-title":"Antibiotics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1128\/AAC.01477-06","volume":"51","author":"Bulitta","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1128\/AAC.00174-11","volume":"55","author":"Pai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000522455","volume":"67","author":"Sakurai","year":"2022","journal-title":"Chemotherapy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20420986251320414","volume":"16","author":"Tseng","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"ref16","unstructured":"Lixoft. Monolix\u00ae user guide. Antony, France: Lixoft SAS; 2024. Available from: https:\/\/monolix.lixoft.com\/. Accessed April 30, 2026."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/phar.2842","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"105847","DOI":"10.1016\/j.ijantimicag.2019.11.004","volume":"55","author":"Babich","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/jac\/dkx209","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cpt197926141","volume":"26","author":"Batra","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013S314. doi:10.1016\/j.kint.2023.10.018","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/pharmacy8010035","volume":"8","author":"Teaford","year":"2020","journal-title":"Pharmacy"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bcp.12501","volume":"79","author":"Chin","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.3346\/jkms.2020.35.e306","volume":"35","author":"Mohd Tahir","year":"2020","journal-title":"J Korean Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"R110","DOI":"10.1186\/cc13899","volume":"18","author":"Frazee","year":"2014","journal-title":"Crit Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/jcm9092803","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"ref30","unstructured":"Sanford guide to antimicrobial therapy. Piperacillin\/tazobactam. Available from: https:\/\/web.sanfordguide.com\/. Accessed January 27, 2026."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jac\/dkx330","volume":"73","author":"Sj\u00f6vall","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/microorganisms9071505","volume":"9","author":"Roger","year":"2021","journal-title":"Microorganisms"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"dlac043","DOI":"10.1093\/jacamr\/dlac043","volume":"4","author":"Suttels","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"Roberts","year":"2021","journal-title":"Clinl Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00654-17","volume":"61","author":"Quinton","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/FTD.0000000000000602","volume":"41","author":"Colman","year":"2019","journal-title":"Therapeutic Drug Monitoring"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/114834","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/114834","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:00:22Z","timestamp":1777978822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/optimal-piperacillintazobactam-dosing-in-adults-with-low-body-weight-a-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2147\/dddt.s602835","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}